Vicore Pharma Holding AB (publ) (FRA:6Y4)

Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	253	173	143	132	97	189
Market Cap Growth	53.11%	21.39%	8.37%	35.38%	-48.72%	169.27%
Enterprise Value	177	140	93	116	54	153
Last Close Price	0.94	0.71	1.25	1.55	1.29	3.02
PS Ratio	329.53	18.13	-	-	-	-
PB Ratio	3.51	1.76	3.48	5.07	2.61	5.37
P/TBV Ratio	3.51	1.76	3.50	6.63	3.16	6.71
EV/Sales Ratio	228.87	14.65	-	-	-	-
Debt / Equity Ratio	-	-	-	0	0.00	0
Asset Turnover	0.01	0.13	-	-	-	-
Quick Ratio	13.49	16.13	11.86	5.69	5.67	6.81
Current Ratio	13.86	16.50	12.10	5.81	5.75	6.82
Return on Equity (ROE)	-72.16%	-21.28%	-83.53%	-85.79%	-80.37%	-43.44%
Return on Assets (ROA)	-40.55%	-13.99%	-47.99%	-45.54%	-42.76%	-27.92%
Return on Capital (ROIC)	-43.91%	-15.02%	-53.87%	-53.41%	-49.68%	-30.86%
Return on Capital Employed (ROCE)	-51.40%	-16.80%	-70.20%	-98.60%	-76.10%	-46.60%
Earnings Yield	-15.15%	-8.51%	-19.63%	-19.69%	-29.68%	-7.72%
FCF Yield	-	-8.32%	-15.75%	-20.47%	-26.55%	-6.30%
Buyback Yield / Dilution	-104.85%	-41.72%	-33.71%	-3.64%	-28.44%	-26.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.